
Allozymes is a Singaporean enzyme engineering start-up that develops enzymes and microbes on an ultra-high-throughput microfluidics platform.
allozymes.comCrawled Nov 2, 2026
Allozymes offers engineered enzyme products for oligonucleotide therapeutics manufacturing, cofactor regeneration, and industrial biocatalysis.
Discover ZymeLeap, Allozymes’ enzyme engineering platform combining ultra-high-throughput microfluidics, computational design, and machine learning for scalable biomanufacturing.
Allozymes develops enzyme engineering, microfluidics, AI-guided design, and oligonucleotide therapeutics manufacturing.
Using ZymeLeap, Allozymes engineers enzymes for next-generation therapeutics manufacturing through microfluidics, computational design, and machine learning.
Allozymes outlines its privacy policy.
Allozymes legal
Allozymes partners with Bonumose to develop enzyme innovations for food and supplement ingredients. The collaboration aims to enhance the production of beneficial bioactive compounds in dietary products. Both companies leverage their expertise in biotechnology to improve ingredient efficacy and sustainability in the nutrition sector.
Mar 2025PR Newswire AsiaNews article
Allozymes and Adisseo collaborate to develop advanced bioprocesses for producing animal feed ingredients. The partnership leverages Allozymes’ microfluidics technology to enhance efficiency and sustainability in feed production. This marks Allozymes’ first major European partnership after expanding into the region.
Aug 2024PR NewswireNews article
Syensqo and Allozymes have signed a Memorandum of Understanding to develop enzyme-based biosolutions for home and personal care products. The collaboration aims to create high-performance, sustainable alternatives for cleaning and care applications.
Jul 2024SEMINews article
Allozymes secures $15 million in Series A funding led by Seventure Partners and Xora Innovation. The company, specializing in enzyme discovery and engineering, plans to expand into Europe and strengthen partnerships in the food and chemical sectors. The investment highlights the potential of its enzymatic solutions to transform industries.
May 2024PR NewswireNews article